Literature DB >> 8146600

Role of T lymphocytes in experimental Staphylococcus aureus arthritis.

A Abdelnour1, T Bremell, R Holmdahl, A Tarkowski.   

Abstract

Using a recently developed murine model of haematogenously induced Staphylococcus aureus, the authors have characterized the phenotypes and functional properties of inflammatory cells present in the synovium of arthritic mice. The results show that large numbers of granulocytes and macrophages were observed in the inflamed synovia within 24 h of inoculation of S. aureus strain LS-1. Many of the synovial macrophage-like cells strained for cytoplasmic IL-1 alpha and TNF-alpha. Subsequently (> or = 48 h later), a prominent infiltration of T lymphocytes, predominantly of CD4+ phenotype, was observed. Some of the T lymphocytes stained for IL-2 receptor and intracytoplasmic interferon-gamma (IFN-gamma). Surprisingly, in spite of the severe inflammatory process, very few cells expressed MHC class-II molecules in the arthritic synovia. In addition, in vivo depletion of CD4+ T-cells resulted in a considerably milder course of staphylococcal arthritis. The similarities in the phenotype expression of synovial cells and central role of T-cells in S. aureus arthritis as well as in non-infectious models of arthritis, indicate that the process governing joint destruction is likely to be the same, irrespective of the initial stimulus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146600     DOI: 10.1111/j.1365-3083.1994.tb03392.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  21 in total

1.  Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance.

Authors:  I Gjertsson; O H Hultgren; A Tarkowski
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia.

Authors:  M Verdrengh; T A Springer; J C Gutierrez-Ramos; A Tarkowski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Adaptive Immunity Against Staphylococcus aureus.

Authors:  Hatice Karauzum; Sandip K Datta
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 4.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis.

Authors:  E Sakiniene; T Bremell; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

6.  Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus.

Authors:  Y X Zhao; A Abdelnour; T Kalland; A Tarkowski
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines.

Authors:  Pinky Mal; Kallol Dutta; Debasish Bandyopadhyay; Anirban Basu; Rajni Khan; Biswadev Bishayi
Journal:  Inflamm Res       Date:  2012-11-15       Impact factor: 4.575

9.  Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci.

Authors:  T Bremell; A Tarkowski
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection.

Authors:  T Bremell; R Holmdahl; A Tarkowski
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.